Pancreatic ductal adenocarcinoma (PDAC) is a class of the commonest malignant
carcinomas. The present study aimed to elucidate the potential biomarker and prognostic …

Background Pancreatic ductal adenocarcinoma (PDAC) is a fatal malignant neoplasm. It is
necessary to improve the understanding of the underlying molecular mechanisms and …

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy. Here we
show that shotgun and targeted protein sequencing can be used to identify potential …

Background Pancreatic cancer is one of the most common malignant cancers worldwide.
Currently, the pathogenesis of pancreatic cancer remains unclear; thus, it is necessary to …

Background The aim of the present study was to construct a novel gene signature on the
tumor microenvironment (TME) to predict the prognosis of patients with pancreatic ductal …

Introduction Transcriptional analyses have identified several distinct molecular subtypes in
pancreatic ductal adenocarcinoma (PDAC) that have prognostic and potential therapeutic …

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease characterized by a dense
desmoplastic reaction surrounding malignant epithelial cells. Interaction between the …

Introduction The poorly differentiated pancreatic adenocarcinoma (PDAC) is an extremely
lethal neoplasm without effective biomarkers for early detection and prognosis prediction …

This study aimed to identify key genes involved in the progression of diabetic pancreatic
ductal adenocarcinoma (PDAC). Two gene expression datasets (GSE74629 and …

Gene expression microarrays have identified many tumor markers and therapeutic targets
for pancreatic ductal adenocarcinoma (PDAC). However, microarray profilings have limited …